Lv1
20 积分 2024-09-06 加入
Efficacy and safety of telitacicept in IgA nephropathy: A retrospective, multicenter study
1天前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
13天前
已完结
IgA Nephropathy
13天前
已完结
Association between triglyceride-glucose index and chronic kidney disease: A cohort study and meta-analysis
1个月前
已完结
Insulin resistance in chronic kidney disease: a systematic review
1个月前
已完结
Insulin resistance in chronic kidney disease: a systematic review
1个月前
已完结
Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases
2个月前
已完结
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
2个月前
已完结
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2个月前
已完结
Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
2个月前
已完结
皖公网安备34019202002308
